Rising drug costs

[...]the price gap between branded medications and generics widened an additional 35.2 percent in the past year, the biggest gap since Express Scripts began calculating this data in 2008. Dr. Steve Miller, the company's chief medical officer, said in a news release that the price disparity betw...

Full description

Saved in:
Bibliographic Details
Published inMcClatchy - Tribune Business News
Main Author Doyle, Jim
Format Newsletter
LanguageEnglish
Published Washington Tribune Content Agency LLC 28.11.2012
Subjects
Blood pressure
Brand names
Cholesterol
Costs
FDA approval
Generic drugs
Hyperlipidemia
Hypertension
Pharmaceutical industry
Pharmacy benefit management
Prescription drug plans
Psychotropic drugs
United States > US
Online AccessGet full text

Cover

More Information
Summary:[...]the price gap between branded medications and generics widened an additional 35.2 percent in the past year, the biggest gap since Express Scripts began calculating this data in 2008. Dr. Steve Miller, the company's chief medical officer, said in a news release that the price disparity between brand-name medications and generics was largely the result in 2012 of the "patent cliff."